| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 12 |
| 1 | CLOPIDOGREL | 11 |
| 2 | METFORMIN | 8 |
| 3 | METFORMIN ER 500 MG | 8 |
| 4 | METFORMIN ER 750 MG | 8 |
| 5 | ASPIRIN | 4 |
| 6 | ASPIRIN 325 MG | 4 |
| 7 | ASPIRIN 81 MG | 4 |
| 8 | ATORVASTATIN CALCIUM | 4 |
| 9 | SIMVASTATIN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOTAGLIFLOZIN | 1 | 0.0018 |
| 1 | BETAINE | 1 | 0.0010 |
| 2 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 3 | COLLAGENASE SANTYL | 1 | 0.0006 |
| 4 | AVATROMBOPAG MALEATE | 1 | 0.0004 |
| 5 | RANOLAZINE | 2 | 0.0002 |
| 6 | BICALUTAMIDE | 2 | 0.0001 |
| 7 | LIDOCAINE PATCH 5% | 1 | 0.0001 |
| 8 | ICOSAPENT ETHYL | 1 | 0.0001 |
| 9 | AGALSIDASE BETA | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 4 |
| 3 | Insulin Analog [EPC] | 3 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 3 |
| 5 | Sulfonylurea [EPC] | 3 |
| 6 | Androgen Receptor Inhibitor [EPC] | 2 |
| 7 | Anti-anginal [EPC] | 2 |
| 8 | Benzodiazepine [EPC] | 2 |
| 9 | Corticosteroid [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Methylating Agent [EPC] | 1 | 0.0010 |
| 1 | Anti-anginal [EPC] | 2 | 0.0002 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Bile Acid [EPC] | 1 | 0.0000 |
| 4 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 7 | Androgen Receptor Inhibitor [EPC] | 2 | 0.0000 |
| 8 | P2Y12 Platelet Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Sulfonylurea [EPC] | 3 | 0.0000 |